US Patent 7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75413670

Patent Inventor Names

George Chiu0

Steven A. Middleton0

Stuart Emanuel0

Yanhua Lu0

Peter J. Connolly0

Ronghui Lin0

Shengjian Li0

Shenlin Huang0

Date of Patent

June 2, 2009

Patent Application Number

114439940

Date Filed

May 31, 2006

Patent Citations Received

‌

US Patent 11697649 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

‌

US Patent 11684615 Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors

‌

US Patent 12012401 Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

‌

US Patent 11780823 Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors

‌

US Patent 11667632 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof

Patent Primary Examiner

‌

D. Margaret Seaman

Patent abstract

The present invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders